Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Make a Bundle on Edwards Lifesciences $EW Increase

Edwards Lifesciences Corp (EW) “third-quarter earnings rose 7.5% on a tax benefit as the heart-valve maker’s investments in its expected Sapien launch hurt margins, despite sales growth,” reports the Wall Street Journal. The news caused EW share prices to swell from $67.79 at close yesterday to $72 at close today.


The following hedge funds made a bundle on the increase:

1. Navellier & Associates – Louis Navellier: Gained $1.9 million

2. Sac Capital Advisors – Steven Cohen: Gained $1.6 million

3. Castlerock Asset Management – Paul Tanico: Gained $1.1 million

4. Driehaus Capital – Richard Driehaus: Gained $826,000

5. Aqr Capital Management – Cliff Asness: Gained $346,000

6. Sirios Capital Management – John Brennan: Gained $289,000

7. Renaissance Technologies – Jim Simons: Gained $287,000

8. Millennium Management – Israel Englander: Gained $223,000

9. Orbimed Advisors – Samuel Isaly: Gained $210,000

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in EW since the end of June. We did not take into account their option positions.